FDA Determines Regulatory Review Period for ABSORB GT1 Bioresorbable Scaffold Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of the ABSORB GT1 Bioresorbable Scaffold, following a submission to the US Patent and Trademark Office (USPTO) by the manufacturer.